LifeNet Health LifeSciences, provider and collaborators in human in vitro biology and drug discovery optimisation, is highlighting innovative human cell and tissue-based research solutions at this year’s ToxExpo.
The showcase includes the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes. It can be found at the Society of Toxicology (SOT) virtual annual meeting and ToxExpo at stand 1322.
Louis Dias, Vice President and General Manager of LifeNet Health LifeSciences said: “Our unique innovations are designed to accelerate drug discovery, validation, and safety testing by bringing new levels of precision and consistency to in vitro biology”.
LifeNet Health LifeSciences will also highlight its portfolio of biospecimens for research, representing more than 50 tissue types recovered under 200 custom protocols, which offers scientists access to both healthy and diseased tissues from precise patient populations.
In addition to the virtual booth presence, LifeNet Health LifeSciences’ subject-matter experts are participating in activities during the meeting. Rony Thomas, LifeNet Health President and CEO said: “These activities provide an opportunity to share how our extraordinary experts are ready to help solve the most pressing challenges in biomedical research.”
